drugset
drugset / Trial / NCT04167267

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers (II)

NCT04167267 ↗

Phase 1 Unknown 24 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedCrossoverOpen-labelBasic science

Summary

This is a randomized, open-label, single dose study to evaluate the safety and pharmacokinetics of DWP14012 tablet A and DWP14012 tablet B in healthy volunteers

Timeline

Start
2019-11
Primary completion
2019-12
Completion
2020-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ABEPRAZAN Small molecule — —

Indications

No indication recorded.